In January, 2019, GlaxoSmithKline, Teva and Takeda partnered with EcoVadis to launch a Responsible Health Initiative. Their aim is to use technology and collaboration to improve the visibility, efficiency and sustainability impact of the global health supply chain. Through this initiative they will be looking to; harmonize industry standards for online CSR assessments, adopt a common platform to share CSR performance and benchmark and implement shared tools to boost supplier engagement.
About the Author
Follow on Twitter Follow on Linkedin Visit Website More Content by EcoVadis EN